[HTML][HTML] Complement as a target in COVID-19?
AM Risitano, DC Mastellos, M Huber-Lang… - Nature Reviews …, 2020 - nature.com
Complement as a target in COVID-19? | Nature Reviews Immunology Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for CSS …
Thank you for visiting nature.com. You are using a browser version with limited support for CSS …
Complement as a target in COVID-19?
AM Risitano, DC Mastellos, M Huber-Lang… - NATURE REVIEWS …, 2020 - iris.unisr.it
Complement as a target in COVID-19? IRIS IRIS Home Sfoglia Macrotipologie & tipologie
Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.IRIS 2.Catalogo Ricerca …
Autore Titolo Riviste Serie IT Italiano Italiano English English LOGIN 1.IRIS 2.Catalogo Ricerca …
[HTML][HTML] Complement as a target in COVID-19?
AM Risitano, DC Mastellos, M Huber-Lang… - Nature Reviews …, 2020 - ncbi.nlm.nih.gov
Additional questions remain concerning the therapeutic use of complement inhibitors for
COVID-19. Only a small proportion of patients develop aggressive disease but reliable …
COVID-19. Only a small proportion of patients develop aggressive disease but reliable …
Complement as a target in COVID-19?
AM Risitano, DC Mastellos… - Nature reviews …, 2020 - pubmed.ncbi.nlm.nih.gov
Complement as a target in COVID-19? Complement as a target in COVID-19? Nat Rev Immunol.
2020 Jun;20(6):343-344. doi: 10.1038/s41577-020-0320-7. Epub 2020 Apr 23. Authors …
2020 Jun;20(6):343-344. doi: 10.1038/s41577-020-0320-7. Epub 2020 Apr 23. Authors …
[PDF][PDF] Complement as a target in COVID-19?
AM Risitano, DC Mastellos, M Huber-Lang… - lambris.com
Additional questions remain concerning the therapeutic use of complement inhibitors for
COVID-19. Only a small proportion of patients develop aggressive disease but reliable …
COVID-19. Only a small proportion of patients develop aggressive disease but reliable …
[引用][C] Complement as a target in COVID-19?
AM Risitano, DC Mastellos, M Huber-Lang… - Nature reviews …, 2020 - oparu.uni-ulm.de
Complement as a target in COVID-19? Toggle navigation English Deutsch Deutsch English
Deutsch Einloggen Toggle navigation Dokumentanzeige Startseite Universität Ulm / Medizin …
Deutsch Einloggen Toggle navigation Dokumentanzeige Startseite Universität Ulm / Medizin …
[HTML][HTML] Complement as a target in COVID-19?
AM Risitano, DC Mastellos, M Huber-Lang… - Nature Reviews …, 2020 - nature.com
There is an urgent need to develop effective therapies for COVID-19. Here, we urge
immunologists and clinicians to consider the potential of targeting the complement system in …
immunologists and clinicians to consider the potential of targeting the complement system in …
Complement as a target in COVID-19?
AM Risitano, DC Mastellos, M Huber-Lang… - Nature Reviews …, 2020 - go.gale.com
Most patients who become critically ill following infection with SARS-CoV-2, the causative
agent of COVID-19, develop acute respiratory distress syndrome (ARDS) 1. The …
agent of COVID-19, develop acute respiratory distress syndrome (ARDS) 1. The …
Complement as a target in COVID-19?
AM Risitano, DC Mastellos, M Huber-Lang… - Nature reviews …, 2020 - europepmc.org
Most patients who become critically ill following infection with SARS-CoV-2, the causative
agent of COVID-19, develop acute respiratory distress syndrome (ARDS) 1. The …
agent of COVID-19, develop acute respiratory distress syndrome (ARDS) 1. The …
Complement as a target in COVID-19?
AM Risitano, DC Mastellos, M Huber-Lang… - 2020 - cabidigitallibrary.org
Skip the header click to show the menu Menu Cart Login Login/Register Institutional Access
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …